APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

GABA Receptor Modulators

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global GABA Receptor Modulators Industry Growth and Trends Forecast to 2032

Report ID 173993690120 December 2025122 pages

Choose your research edition.

Industry ResearchGABA Receptor Modulators Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal GABA Receptor Modulators Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal GABA Receptor Modulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal GABA Receptor Modulators Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal GABA Receptor Modulators Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global GABA Receptor Modulators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for GABA Receptor Modulators is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of GABA Receptor Modulators include Takeda, Teva, Sun Pharma, Shanghai Pharmaceuticals Holding, Sanofi, Novartis, Mylan, Roche and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global GABA Receptor Modulators market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The GABA Receptor Modulators market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global GABA Receptor Modulators market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to GABA Receptor Modulators.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global GABA Receptor Modulators market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

GABA Receptor Modulators Market by Company

Takeda

Teva

Sun Pharma

Shanghai Pharmaceuticals Holding

Sanofi

Novartis

Mylan

Roche

Pfizer

Huazhong Pharmaceutical

Sichuan HaiscoPharmaceuical

GSK

Fresenius Kabi

Changzhou Siyao Pharmaceutical

AstraZeneca

WG Critical Care

Viatris

Torrent Pharma

Sandoz

SAGE Therapeutics

Neurelis

Jazz Pharmaceuicals

Hikma

CHEPLAPHARM

Apotex

Akorn

GABA Receptor Modulators Segment by Type

GABAA Receptors

GABAB Receptors

GABAC Receptors

GABA Receptor Modulators Segment by Application

Epilepsy

Anxiety

Neuropathic Pain

Insomnia

Other

GABA Receptor Modulators Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GABA Receptor Modulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of GABA Receptor Modulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GABA Receptor Modulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of GABA Receptor Modulators manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of GABA Receptor Modulators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of GABAA Receptors Table 2. Major Company of GABAB Receptors Table 3. Major Company of GABAC Receptors Table 4. Global GABA Receptor Modulators Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 6. Global GABA Receptor Modulators Sales Market Share in Volume by Type (2021-2026) Table 7. Global GABA Receptor Modulators Sales by Type (2021-2026) & (US$ Million) Table 8. Global GABA Receptor Modulators Sales Market Share in Value by Type (2021-2026) Table 9. Global GABA Receptor Modulators Price by Type (2021-2026) & (US$/Unit) Table 10. Global GABA Receptor Modulators Sales by Type (2027-2032) & (K Units) Table 11. Global GABA Receptor Modulators Sales Market Share in Volume by Type (2027-2032) Table 12. Global GABA Receptor Modulators Sales by Type (2027-2032) & (US$ Million) Table 13. Global GABA Receptor Modulators Sales Market Share in Value by Type (2027-2032) Table 14. Global GABA Receptor Modulators Price by Type (2027-2032) & (US$/Unit) Table 15. North America GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 16. North America GABA Receptor Modulators Sales by Type (2021-2026) & (US$ Million) Table 17. Europe GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 18. Europe GABA Receptor Modulators Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific GABA Receptor Modulators Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 22. Latin America GABA Receptor Modulators Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa GABA Receptor Modulators Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa GABA Receptor Modulators Sales by Type (2021-2026) & (US$ Million) Table 25. GABA Receptor Modulators Industry Trends Table 26. GABA Receptor Modulators Industry Drivers Table 27. GABA Receptor Modulators Industry Opportunities and Challenges Table 28. GABA Receptor Modulators Industry Restraints Table 29. Global GABA Receptor Modulators Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global GABA Receptor Modulators Revenue Market Share by Company (2021-2026) Table 31. Global GABA Receptor Modulators Sales by Company (2021-2026) & (K Units) Table 32. Global GABA Receptor Modulators Sales Share by Company (2021-2026) Table 33. Global GABA Receptor Modulators Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global GABA Receptor Modulators Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global GABA Receptor Modulators Major Company Production Sites and Headquarters Table 36. Global GABA Receptor Modulators Company, Product Type & Application Table 37. Global GABA Receptor Modulators Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global GABA Receptor Modulators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global GABA Receptor Modulators Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global GABA Receptor Modulators Sales by Region (2021-2026) & (K Units) Table 42. Global GABA Receptor Modulators Sales Market Share in Volume by Region (2021-2026) Table 43. Global GABA Receptor Modulators Sales by Region (2021-2026) & (US$ Million) Table 44. Global GABA Receptor Modulators Sales Market Share in Value by Region (2021-2026) Table 45. Global GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global GABA Receptor Modulators Sales by Region (2027-2032) & (K Units) Table 47. Global GABA Receptor Modulators Sales Market Share in Volume by Region (2027-2032) Table 48. Global GABA Receptor Modulators Sales by Region (2027-2032) & (US$ Million) Table 49. Global GABA Receptor Modulators Sales Market Share in Value by Region (2027-2032) Table 50. Global GABA Receptor Modulators Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global GABA Receptor Modulators Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 53. Global GABA Receptor Modulators Sales Market Share in Volume by Application (2021-2026) Table 54. Global GABA Receptor Modulators Sales by Application (2021-2026) & (US$ Million) Table 55. Global GABA Receptor Modulators Sales Market Share in Value by Application (2021-2026) Table 56. Global GABA Receptor Modulators Price by Application (2021-2026) & (US$/Unit) Table 57. Global GABA Receptor Modulators Sales by Application (2027-2032) & (K Units) Table 58. Global GABA Receptor Modulators Sales Market Share in Volume by Application (2027-2032) Table 59. Global GABA Receptor Modulators Sales by Application (2027-2032) & (US$ Million) Table 60. Global GABA Receptor Modulators Sales Market Share in Value by Application (2027-2032) Table 61. Global GABA Receptor Modulators Price by Application (2027-2032) & (US$/Unit) Table 62. North America GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 63. North America GABA Receptor Modulators Sales by Application (2021-2026) & (US$ Million) Table 64. Europe GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 65. Europe GABA Receptor Modulators Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific GABA Receptor Modulators Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 69. Latin America GABA Receptor Modulators Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa GABA Receptor Modulators Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa GABA Receptor Modulators Sales by Application (2021-2026) & (US$ Million) Table 72. Takeda Company Information Table 73. Takeda Business Overview Table 74. Takeda GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Takeda GABA Receptor Modulators Product Portfolio Table 76. Takeda Recent Development Table 77. Teva Company Information Table 78. Teva Business Overview Table 79. Teva GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Teva GABA Receptor Modulators Product Portfolio Table 81. Teva Recent Development Table 82. Sun Pharma Company Information Table 83. Sun Pharma Business Overview Table 84. Sun Pharma GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sun Pharma GABA Receptor Modulators Product Portfolio Table 86. Sun Pharma Recent Development Table 87. Shanghai Pharmaceuticals Holding Company Information Table 88. Shanghai Pharmaceuticals Holding Business Overview Table 89. Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Portfolio Table 91. Shanghai Pharmaceuticals Holding Recent Development Table 92. Sanofi Company Information Table 93. Sanofi Business Overview Table 94. Sanofi GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sanofi GABA Receptor Modulators Product Portfolio Table 96. Sanofi Recent Development Table 97. Novartis Company Information Table 98. Novartis Business Overview Table 99. Novartis GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Novartis GABA Receptor Modulators Product Portfolio Table 101. Novartis Recent Development Table 102. Mylan Company Information Table 103. Mylan Business Overview Table 104. Mylan GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Mylan GABA Receptor Modulators Product Portfolio Table 106. Mylan Recent Development Table 107. Roche Company Information Table 108. Roche Business Overview Table 109. Roche GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Roche GABA Receptor Modulators Product Portfolio Table 111. Roche Recent Development Table 112. Pfizer Company Information Table 113. Pfizer Business Overview Table 114. Pfizer GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Pfizer GABA Receptor Modulators Product Portfolio Table 116. Pfizer Recent Development Table 117. Huazhong Pharmaceutical Company Information Table 118. Huazhong Pharmaceutical Business Overview Table 119. Huazhong Pharmaceutical GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Huazhong Pharmaceutical GABA Receptor Modulators Product Portfolio Table 121. Huazhong Pharmaceutical Recent Development Table 122. Sichuan HaiscoPharmaceuical Company Information Table 123. Sichuan HaiscoPharmaceuical Business Overview Table 124. Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Portfolio Table 126. Sichuan HaiscoPharmaceuical Recent Development Table 127. GSK Company Information Table 128. GSK Business Overview Table 129. GSK GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. GSK GABA Receptor Modulators Product Portfolio Table 131. GSK Recent Development Table 132. Fresenius Kabi Company Information Table 133. Fresenius Kabi Business Overview Table 134. Fresenius Kabi GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Fresenius Kabi GABA Receptor Modulators Product Portfolio Table 136. Fresenius Kabi Recent Development Table 137. Changzhou Siyao Pharmaceutical Company Information Table 138. Changzhou Siyao Pharmaceutical Business Overview Table 139. Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Portfolio Table 141. Changzhou Siyao Pharmaceutical Recent Development Table 142. AstraZeneca Company Information Table 143. AstraZeneca Business Overview Table 144. AstraZeneca GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. AstraZeneca GABA Receptor Modulators Product Portfolio Table 146. AstraZeneca Recent Development Table 147. WG Critical Care Company Information Table 148. WG Critical Care Business Overview Table 149. WG Critical Care GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. WG Critical Care GABA Receptor Modulators Product Portfolio Table 151. WG Critical Care Recent Development Table 152. Viatris Company Information Table 153. Viatris Business Overview Table 154. Viatris GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 155. Viatris GABA Receptor Modulators Product Portfolio Table 156. Viatris Recent Development Table 157. Torrent Pharma Company Information Table 158. Torrent Pharma Business Overview Table 159. Torrent Pharma GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 160. Torrent Pharma GABA Receptor Modulators Product Portfolio Table 161. Torrent Pharma Recent Development Table 162. Sandoz Company Information Table 163. Sandoz Business Overview Table 164. Sandoz GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 165. Sandoz GABA Receptor Modulators Product Portfolio Table 166. Sandoz Recent Development Table 167. SAGE Therapeutics Company Information Table 168. SAGE Therapeutics Business Overview Table 169. SAGE Therapeutics GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 170. SAGE Therapeutics GABA Receptor Modulators Product Portfolio Table 171. SAGE Therapeutics Recent Development Table 172. Neurelis Company Information Table 173. Neurelis Business Overview Table 174. Neurelis GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 175. Neurelis GABA Receptor Modulators Product Portfolio Table 176. Neurelis Recent Development Table 177. Jazz Pharmaceuicals Company Information Table 178. Jazz Pharmaceuicals Business Overview Table 179. Jazz Pharmaceuicals GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 180. Jazz Pharmaceuicals GABA Receptor Modulators Product Portfolio Table 181. Jazz Pharmaceuicals Recent Development Table 182. Hikma Company Information Table 183. Hikma Business Overview Table 184. Hikma GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 185. Hikma GABA Receptor Modulators Product Portfolio Table 186. Hikma Recent Development Table 187. CHEPLAPHARM Company Information Table 188. CHEPLAPHARM Business Overview Table 189. CHEPLAPHARM GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 190. CHEPLAPHARM GABA Receptor Modulators Product Portfolio Table 191. CHEPLAPHARM Recent Development Table 192. Apotex Company Information Table 193. Apotex Business Overview Table 194. Apotex GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 195. Apotex GABA Receptor Modulators Product Portfolio Table 196. Apotex Recent Development Table 197. Akorn Company Information Table 198. Akorn Business Overview Table 199. Akorn GABA Receptor Modulators Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 200. Akorn GABA Receptor Modulators Product Portfolio Table 201. Akorn Recent Development Table 202. North America GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 203. North America GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 204. North America GABA Receptor Modulators Sales Market Share by Country (2021-2026) Table 205. North America GABA Receptor Modulators Sales Forecast by Country (2027-2032) & (K Units) Table 206. North America GABA Receptor Modulators Sales Market Share Forecast by Country (2027-2032) Table 207. North America GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. North America GABA Receptor Modulators Market Size by Country (2021-2026) & (US$ Million) Table 209. North America GABA Receptor Modulators Market Share by Country (2021-2026) Table 210. North America GABA Receptor Modulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. North America GABA Receptor Modulators Market Share Forecast by Country (2027-2032) Table 212. Europe GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 213. Europe GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 214. Europe GABA Receptor Modulators Sales Market Share by Country (2021-2026) Table 215. Europe GABA Receptor Modulators Sales Forecast by Country (2027-2032) & (K Units) Table 216. Europe GABA Receptor Modulators Sales Market Share Forecast by Country (2027-2032) Table 217. Europe GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 218. Europe GABA Receptor Modulators Market Size by Country (2021-2026) & (US$ Million) Table 219. Europe GABA Receptor Modulators Market Share by Country (2021-2026) Table 220. Europe GABA Receptor Modulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 221. Europe GABA Receptor Modulators Market Share Forecast by Country (2027-2032) Table 222. Asia-Pacific GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 223. Asia-Pacific GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 224. Asia-Pacific GABA Receptor Modulators Sales Market Share by Country (2021-2026) Table 225. Asia-Pacific GABA Receptor Modulators Sales Forecast by Country (2027-2032) & (K Units) Table 226. Asia-Pacific GABA Receptor Modulators Sales Market Share Forecast by Country (2027-2032) Table 227. Asia-Pacific GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 228. Asia-Pacific GABA Receptor Modulators Market Size by Country (2021-2026) & (US$ Million) Table 229. Asia-Pacific GABA Receptor Modulators Market Share by Country (2021-2026) Table 230. Asia-Pacific GABA Receptor Modulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 231. Asia-Pacific GABA Receptor Modulators Market Share Forecast by Country (2027-2032) Table 232. Latin America GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 233. Latin America GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 234. Latin America GABA Receptor Modulators Sales Market Share by Country (2021-2026) Table 235. Latin America GABA Receptor Modulators Sales Forecast by Country (2027-2032) & (K Units) Table 236. Latin America GABA Receptor Modulators Sales Market Share Forecast by Country (2027-2032) Table 237. Latin America GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 238. Latin America GABA Receptor Modulators Market Size by Country (2021-2026) & (US$ Million) Table 239. Latin America GABA Receptor Modulators Market Share by Country (2021-2026) Table 240. Latin America GABA Receptor Modulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 241. Latin America GABA Receptor Modulators Market Share Forecast by Country (2027-2032) Table 242. Middle East and Africa GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 243. Middle East and Africa GABA Receptor Modulators Sales by Country (2021-2026) & (K Units) Table 244. Middle East and Africa GABA Receptor Modulators Sales Market Share by Country (2021-2026) Table 245. Middle East and Africa GABA Receptor Modulators Sales Forecast by Country (2027-2032) & (K Units) Table 246. Middle East and Africa GABA Receptor Modulators Sales Market Share Forecast by Country (2027-2032) Table 247. Middle East and Africa GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 248. Middle East and Africa GABA Receptor Modulators Market Size by Country (2021-2026) & (US$ Million) Table 249. Middle East and Africa GABA Receptor Modulators Market Share by Country (2021-2026) Table 250. Middle East and Africa GABA Receptor Modulators Market Size Forecast by Country (2027-2032) & (US$ Million) Table 251. Middle East and Africa GABA Receptor Modulators Market Share Forecast by Country (2027-2032) Table 252. Key Raw Materials Table 253. Raw Materials Key Suppliers Table 254. GABA Receptor Modulators Distributors List Table 255. GABA Receptor Modulators Customers List Table 256. Research Programs/Design for This Report Table 257. Authors List of This Report Table 258. Secondary Sources Table 259. Primary Sources List of Figures Figure 1. GABA Receptor Modulators Image Figure 2. Global GABA Receptor Modulators Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global GABA Receptor Modulators Market Size (2021-2032) & (US$ Million) Figure 4. Global GABA Receptor Modulators Sales (2021-2032) & (K Units) Figure 5. GABAA Receptors Image Figure 6. Global GABAA Receptors Sales YoY Growth (2021-2032) & (K Units) Figure 7. GABAB Receptors Image Figure 8. Global GABAB Receptors Sales YoY Growth (2021-2032) & (K Units) Figure 9. GABAC Receptors Image Figure 10. Global GABAC Receptors Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global GABA Receptor Modulators Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global GABA Receptor Modulators Market Share by Type 2025 VS 2032 Figure 13. North America GABA Receptor Modulators Sales Market Share in Volume by Type in 2025 Figure 14. North America GABA Receptor Modulators Sales Market Share in Value by Type in 2025 Figure 15. Europe GABA Receptor Modulators Sales Market Share in Volume by Type in 2025 Figure 16. Europe GABA Receptor Modulators Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific GABA Receptor Modulators Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific GABA Receptor Modulators Sales Market Share in Value by Type in 2025 Figure 19. Latin America GABA Receptor Modulators Sales Market Share in Volume by Type in 2025 Figure 20. Latin America GABA Receptor Modulators Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa GABA Receptor Modulators Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa GABA Receptor Modulators Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 GABA Receptor Modulators Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Epilepsy Image Figure 26. Global Epilepsy Sales YoY Growth (2021-2032) & (K Units) Figure 27. Anxiety Image Figure 28. Global Anxiety Sales YoY Growth (2021-2032) & (K Units) Figure 29. Neuropathic Pain Image Figure 30. Global Neuropathic Pain Sales YoY Growth (2021-2032) & (K Units) Figure 31. Insomnia Image Figure 32. Global Insomnia Sales YoY Growth (2021-2032) & (K Units) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global GABA Receptor Modulators Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global GABA Receptor Modulators Market Share by Application 2025 VS 2032 Figure 37. North America GABA Receptor Modulators Sales Market Share in Volume by Application in 2025 Figure 38. North America GABA Receptor Modulators Sales Market Share in Value by Application in 2025 Figure 39. Europe GABA Receptor Modulators Sales Market Share in Volume by Application in 2025 Figure 40. Europe GABA Receptor Modulators Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific GABA Receptor Modulators Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific GABA Receptor Modulators Sales Market Share in Value by Application in 2025 Figure 43. Latin America GABA Receptor Modulators Sales Market Share in Volume by Application in 2025 Figure 44. Latin America GABA Receptor Modulators Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa GABA Receptor Modulators Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa GABA Receptor Modulators Sales Market Share in Value by Application in 2025 Figure 47. North America GABA Receptor Modulators Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America GABA Receptor Modulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America GABA Receptor Modulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America GABA Receptor Modulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe GABA Receptor Modulators Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe GABA Receptor Modulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe GABA Receptor Modulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe GABA Receptor Modulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific GABA Receptor Modulators Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific GABA Receptor Modulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific GABA Receptor Modulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific GABA Receptor Modulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America GABA Receptor Modulators Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America GABA Receptor Modulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America GABA Receptor Modulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America GABA Receptor Modulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa GABA Receptor Modulators Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa GABA Receptor Modulators Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa GABA Receptor Modulators Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa GABA Receptor Modulators Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. GABA Receptor Modulators Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. GABA Receptor Modulators Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • GABAA Receptors
  • GABAB Receptors
  • GABAC Receptors
Applications
  • Epilepsy
  • Anxiety
  • Neuropathic Pain
  • Insomnia
  • Other
Companies covered
  • Takeda
  • Teva
  • Sun Pharma
  • Shanghai Pharmaceuticals Holding
  • Sanofi
  • Novartis
  • Mylan
  • Roche
  • Pfizer
  • Huazhong Pharmaceutical
  • Sichuan HaiscoPharmaceuical
  • GSK
  • Fresenius Kabi
  • Changzhou Siyao Pharmaceutical
  • AstraZeneca
  • WG Critical Care
  • Viatris
  • Torrent Pharma
  • Sandoz
  • SAGE Therapeutics
  • Neurelis
  • Jazz Pharmaceuicals
  • Hikma
  • CHEPLAPHARM
  • Apotex
  • Akorn

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global GABA Receptor Modulators Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global GABA Receptor Modulators Sales Estimates and Forecasts (2021-2032)
  5. 1.3 GABA Receptor Modulators Market by Type
  6. 1.3.1 GABAA Receptors
  7. 1.3.2 GABAB Receptors
  8. 1.3.3 GABAC Receptors
  9. 1.4 Global GABA Receptor Modulators Market Size by Type
  10. 1.4.1 Global GABA Receptor Modulators Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global GABA Receptor Modulators Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global GABA Receptor Modulators Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America GABA Receptor Modulators Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe GABA Receptor Modulators Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific GABA Receptor Modulators Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America GABA Receptor Modulators Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa GABA Receptor Modulators Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 GABA Receptor Modulators Industry Trends
  2. 2.2 GABA Receptor Modulators Industry Drivers
  3. 2.3 GABA Receptor Modulators Industry Opportunities and Challenges
  4. 2.4 GABA Receptor Modulators Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by GABA Receptor Modulators Revenue (2021-2026)
  2. 3.2 Global Top Players by GABA Receptor Modulators Sales (2021-2026)
  3. 3.3 Global Top Players by GABA Receptor Modulators Price (2021-2026)
  4. 3.4 Global GABA Receptor Modulators Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global GABA Receptor Modulators Major Company Production Sites & Headquarters
  6. 3.6 Global GABA Receptor Modulators Company, Product Type & Application
  7. 3.7 Global GABA Receptor Modulators Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global GABA Receptor Modulators Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 GABA Receptor Modulators Players Market Share by Revenue in 2025
  11. 3.8.3 2025 GABA Receptor Modulators Tier 1, Tier 2, and Tier 3
4 GABA Receptor Modulators Regional Status and Outlook
  1. 4.1 Global GABA Receptor Modulators Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global GABA Receptor Modulators Historic Market Size by Region
  3. 4.2.1 Global GABA Receptor Modulators Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global GABA Receptor Modulators Sales in Value by Region (2021-2026)
  5. 4.2.3 Global GABA Receptor Modulators Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global GABA Receptor Modulators Forecasted Market Size by Region
  7. 4.3.1 Global GABA Receptor Modulators Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global GABA Receptor Modulators Sales in Value by Region (2027-2032)
  9. 4.3.3 Global GABA Receptor Modulators Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 GABA Receptor Modulators by Application
  1. 5.1 GABA Receptor Modulators Market by Application
  2. 5.1.1 Epilepsy
  3. 5.1.2 Anxiety
  4. 5.1.3 Neuropathic Pain
  5. 5.1.4 Insomnia
  6. 5.1.5 Other
  7. 5.2 Global GABA Receptor Modulators Market Size by Application
  8. 5.2.1 Global GABA Receptor Modulators Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global GABA Receptor Modulators Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global GABA Receptor Modulators Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America GABA Receptor Modulators Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe GABA Receptor Modulators Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific GABA Receptor Modulators Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America GABA Receptor Modulators Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa GABA Receptor Modulators Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda GABA Receptor Modulators Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Teva
  8. 6.2.1 Teva Company Information
  9. 6.2.2 Teva Business Overview
  10. 6.2.3 Teva GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva GABA Receptor Modulators Product Portfolio
  12. 6.2.5 Teva Recent Developments
  13. 6.3 Sun Pharma
  14. 6.3.1 Sun Pharma Company Information
  15. 6.3.2 Sun Pharma Business Overview
  16. 6.3.3 Sun Pharma GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sun Pharma GABA Receptor Modulators Product Portfolio
  18. 6.3.5 Sun Pharma Recent Developments
  19. 6.4 Shanghai Pharmaceuticals Holding
  20. 6.4.1 Shanghai Pharmaceuticals Holding Company Information
  21. 6.4.2 Shanghai Pharmaceuticals Holding Business Overview
  22. 6.4.3 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Pharmaceuticals Holding GABA Receptor Modulators Product Portfolio
  24. 6.4.5 Shanghai Pharmaceuticals Holding Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sanofi GABA Receptor Modulators Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Novartis GABA Receptor Modulators Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan GABA Receptor Modulators Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Roche GABA Receptor Modulators Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer GABA Receptor Modulators Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Huazhong Pharmaceutical
  56. 6.10.1 Huazhong Pharmaceutical Company Information
  57. 6.10.2 Huazhong Pharmaceutical Business Overview
  58. 6.10.3 Huazhong Pharmaceutical GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Huazhong Pharmaceutical GABA Receptor Modulators Product Portfolio
  60. 6.10.5 Huazhong Pharmaceutical Recent Developments
  61. 6.11 Sichuan HaiscoPharmaceuical
  62. 6.11.1 Sichuan HaiscoPharmaceuical Company Information
  63. 6.11.2 Sichuan HaiscoPharmaceuical Business Overview
  64. 6.11.3 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Sichuan HaiscoPharmaceuical GABA Receptor Modulators Product Portfolio
  66. 6.11.5 Sichuan HaiscoPharmaceuical Recent Developments
  67. 6.12 GSK
  68. 6.12.1 GSK Company Information
  69. 6.12.2 GSK Business Overview
  70. 6.12.3 GSK GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 GSK GABA Receptor Modulators Product Portfolio
  72. 6.12.5 GSK Recent Developments
  73. 6.13 Fresenius Kabi
  74. 6.13.1 Fresenius Kabi Company Information
  75. 6.13.2 Fresenius Kabi Business Overview
  76. 6.13.3 Fresenius Kabi GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Fresenius Kabi GABA Receptor Modulators Product Portfolio
  78. 6.13.5 Fresenius Kabi Recent Developments
  79. 6.14 Changzhou Siyao Pharmaceutical
  80. 6.14.1 Changzhou Siyao Pharmaceutical Company Information
  81. 6.14.2 Changzhou Siyao Pharmaceutical Business Overview
  82. 6.14.3 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Changzhou Siyao Pharmaceutical GABA Receptor Modulators Product Portfolio
  84. 6.14.5 Changzhou Siyao Pharmaceutical Recent Developments
  85. 6.15 AstraZeneca
  86. 6.15.1 AstraZeneca Company Information
  87. 6.15.2 AstraZeneca Business Overview
  88. 6.15.3 AstraZeneca GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 AstraZeneca GABA Receptor Modulators Product Portfolio
  90. 6.15.5 AstraZeneca Recent Developments
  91. 6.16 WG Critical Care
  92. 6.16.1 WG Critical Care Company Information
  93. 6.16.2 WG Critical Care Business Overview
  94. 6.16.3 WG Critical Care GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 WG Critical Care GABA Receptor Modulators Product Portfolio
  96. 6.16.5 WG Critical Care Recent Developments
  97. 6.17 Viatris
  98. 6.17.1 Viatris Company Information
  99. 6.17.2 Viatris Business Overview
  100. 6.17.3 Viatris GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Viatris GABA Receptor Modulators Product Portfolio
  102. 6.17.5 Viatris Recent Developments
  103. 6.18 Torrent Pharma
  104. 6.18.1 Torrent Pharma Company Information
  105. 6.18.2 Torrent Pharma Business Overview
  106. 6.18.3 Torrent Pharma GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Torrent Pharma GABA Receptor Modulators Product Portfolio
  108. 6.18.5 Torrent Pharma Recent Developments
  109. 6.19 Sandoz
  110. 6.19.1 Sandoz Company Information
  111. 6.19.2 Sandoz Business Overview
  112. 6.19.3 Sandoz GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Sandoz GABA Receptor Modulators Product Portfolio
  114. 6.19.5 Sandoz Recent Developments
  115. 6.20 SAGE Therapeutics
  116. 6.20.1 SAGE Therapeutics Company Information
  117. 6.20.2 SAGE Therapeutics Business Overview
  118. 6.20.3 SAGE Therapeutics GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 SAGE Therapeutics GABA Receptor Modulators Product Portfolio
  120. 6.20.5 SAGE Therapeutics Recent Developments
  121. 6.21 Neurelis
  122. 6.21.1 Neurelis Company Information
  123. 6.21.2 Neurelis Business Overview
  124. 6.21.3 Neurelis GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Neurelis GABA Receptor Modulators Product Portfolio
  126. 6.21.5 Neurelis Recent Developments
  127. 6.22 Jazz Pharmaceuicals
  128. 6.22.1 Jazz Pharmaceuicals Company Information
  129. 6.22.2 Jazz Pharmaceuicals Business Overview
  130. 6.22.3 Jazz Pharmaceuicals GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Jazz Pharmaceuicals GABA Receptor Modulators Product Portfolio
  132. 6.22.5 Jazz Pharmaceuicals Recent Developments
  133. 6.23 Hikma
  134. 6.23.1 Hikma Company Information
  135. 6.23.2 Hikma Business Overview
  136. 6.23.3 Hikma GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Hikma GABA Receptor Modulators Product Portfolio
  138. 6.23.5 Hikma Recent Developments
  139. 6.24 CHEPLAPHARM
  140. 6.24.1 CHEPLAPHARM Company Information
  141. 6.24.2 CHEPLAPHARM Business Overview
  142. 6.24.3 CHEPLAPHARM GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 CHEPLAPHARM GABA Receptor Modulators Product Portfolio
  144. 6.24.5 CHEPLAPHARM Recent Developments
  145. 6.25 Apotex
  146. 6.25.1 Apotex Company Information
  147. 6.25.2 Apotex Business Overview
  148. 6.25.3 Apotex GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Apotex GABA Receptor Modulators Product Portfolio
  150. 6.25.5 Apotex Recent Developments
  151. 6.26 Akorn
  152. 6.26.1 Akorn Company Information
  153. 6.26.2 Akorn Business Overview
  154. 6.26.3 Akorn GABA Receptor Modulators Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 Akorn GABA Receptor Modulators Product Portfolio
  156. 6.26.5 Akorn Recent Developments
7 North America by Country
  1. 7.1 North America GABA Receptor Modulators Sales by Country
  2. 7.1.1 North America GABA Receptor Modulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America GABA Receptor Modulators Sales by Country (2021-2026)
  4. 7.1.3 North America GABA Receptor Modulators Sales Forecast by Country (2027-2032)
  5. 7.2 North America GABA Receptor Modulators Market Size by Country
  6. 7.2.1 North America GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America GABA Receptor Modulators Market Size by Country (2021-2026)
  8. 7.2.3 North America GABA Receptor Modulators Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe GABA Receptor Modulators Sales by Country
  2. 8.1.1 Europe GABA Receptor Modulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe GABA Receptor Modulators Sales by Country (2021-2026)
  4. 8.1.3 Europe GABA Receptor Modulators Sales Forecast by Country (2027-2032)
  5. 8.2 Europe GABA Receptor Modulators Market Size by Country
  6. 8.2.1 Europe GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe GABA Receptor Modulators Market Size by Country (2021-2026)
  8. 8.2.3 Europe GABA Receptor Modulators Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific GABA Receptor Modulators Sales by Country
  2. 9.1.1 Asia-Pacific GABA Receptor Modulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific GABA Receptor Modulators Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific GABA Receptor Modulators Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific GABA Receptor Modulators Market Size by Country
  6. 9.2.1 Asia-Pacific GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific GABA Receptor Modulators Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific GABA Receptor Modulators Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America GABA Receptor Modulators Sales by Country
  2. 10.1.1 South America GABA Receptor Modulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America GABA Receptor Modulators Sales by Country (2021-2026)
  4. 10.1.3 South America GABA Receptor Modulators Sales Forecast by Country (2027-2032)
  5. 10.2 South America GABA Receptor Modulators Market Size by Country
  6. 10.2.1 South America GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America GABA Receptor Modulators Market Size by Country (2021-2026)
  8. 10.2.3 South America GABA Receptor Modulators Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa GABA Receptor Modulators Sales by Country
  2. 11.1.1 Middle East and Africa GABA Receptor Modulators Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa GABA Receptor Modulators Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa GABA Receptor Modulators Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa GABA Receptor Modulators Market Size by Country
  6. 11.2.1 Middle East and Africa GABA Receptor Modulators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa GABA Receptor Modulators Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa GABA Receptor Modulators Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 GABA Receptor Modulators Value Chain Analysis
  2. 12.1.1 GABA Receptor Modulators Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 GABA Receptor Modulators Production Mode & Process
  7. 12.2 GABA Receptor Modulators Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 GABA Receptor Modulators Distributors
  10. 12.2.3 GABA Receptor Modulators Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst